ABUS vs MCD
Arbutus Biopharma Corp (ABUS) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the ABUS and MCD stock pages for the full models.
Not investment advice.